Tk. Smith et al., Specificity of GlcNAc-Pl de-N-acetylase of GPI biosynthesis and synthesis of parasite-specific suicide substrate inhibitors, EMBO J, 20(13), 2001, pp. 3322-3332
The substrate specificities of Trypanosoma brucei and human (HeLa) GlcNAc-P
I de-N-acetylases were determined using 24 substrate analogues. The results
show the following. (i) The de-N-acetylases show little specificity for th
e lipid moiety of GlcNAc-PI, (ii) The 3 ' -OH group of the GlcNAc residue i
s essential for substrate recognition whereas the 6 ' -OH group is dispensa
ble and the 4 ' -OH, while not required for recognition, cannot be epimeriz
ed or substituted, (iii) The parasite enzyme can act on analogues containin
g beta GlcNAc or aromatic N-acyl groups, whereas the human enzyme cannot, (
iv) Three GlcNR-PI analogues are de-N-acetylase inhibitors, one of which is
a suicide inhibitor, (v) The suicide inhibitor most likely forms a carbama
te or thiocarbamate ester to an active site hydroxy-amino acid or Cys or re
sidue such that inhibition is reversed by certain nucleophiles, These and p
revious results were used to design two potent (IC50 = 8 nM) parasite-speci
fic suicide substrate inhibitors. These are potential lead compounds for th
e development of anti-protozoan parasite drugs.